Cannabis for Nerve Pain: Mixed Evidence From 22 Trials, No Clear Winners Yet
Neuropathic pain cannabis treatment shows promise but remains inconclusive due to study limitations. Trials reveal mixed evidence with no definitive winners yet. Careful dosing and further research are essential for clinical guidance.
Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis.
A comprehensive systematic review of cannabis inflammatory biomarkers found associations with anti-inflammatory markers in observational studies. However, the clinical significance of these laboratory changes remains uncertain, and the predominance of…
Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.
A comprehensive systematic review and meta-analysis examining medicinal cannabis quality of life outcomes found consistent improvements across chronic conditions. The research analyzed validated HRQL measures from 2015-2025, showing benefits in short,…
Prevalence of Schizophrenia Spectrum and Bipolar Disorder in Cannabis Induced Psychosis Patients
Distinguishing cannabis induced psychosis prevalence from primary psychiatric disorders is challenging and clinically important. This systematic review and meta-analysis examines the prevalence of schizophrenia spectrum and bipolar disorder among these…
The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
Major depressive disorder cannabis use is a critical area of study due to frequent co-occurrence. This meta-analysis examines prevalence estimates and clinical relevance. Understanding this association aids clinicians in patient care.
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
Neuropsychiatric symptoms (NPS) are highly prevalent in persons with dementia and have been associated with adverse health outcomes. Neuropsychiatric symptom...
Effect of Glucagon-Like-Peptide-1 Receptor Agonists on Neuropsychiatric Outcomes
This meta-analysis examines GLP-1 receptor agonists neuropsychiatric effects across 82 studies. Evidence suggests potential benefits including Parkinson's disease risk reduction. However, the quality of evidence limits clinical recommendations beyond…
Understanding Maternal Cannabis Use and Autism Risk in Pregnancy
Maternal cannabis use pregnancy autism risk is a growing concern based on recent meta-analyses. Studies show a 30% increased risk of autism spectrum disorder in offspring exposed to cannabis in utero. These findings highlight the importance of…
Analgesic Effect of Cannabinoids for Fibromyalgia: A Systematic Review and Meta-Analysis.
This systematic review and meta-analysis examines cannabinoid analgesic effects fibromyalgia patients experience. It provides evidence on cannabinoids as a potential treatment for fibromyalgia pain. The study highlights the importance of considering…
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
Neuropsychiatric symptoms (NPS) are highly prevalent in persons with dementia and have been associated with adverse health outcomes. Neuropsychiatric symptom...